The Memocore 066 fiducial stent marker was developed by a team lead by CTO Erik Othel-Jacobsen, Pnn Medical A/S. Memocore 066 represents incremental innovation since the technology closely resemble the technique used in the Memokath product line. Memokath stents have been in use since the early 1990es and an estimated 45,000 patients have been exposed to the stents. The Memocore 066s visibility on high volt images also provides better radiotherapy on old equipment. This will improve the treatment effect/side-effect ratio for patients treated with old equipment.
Product URL : http://www.pnnmedical.com/en/oncology/professional
Last Updated : 03/16/2013